These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28041810)

  • 1. The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2016.
    Ramakrishna H; Gutsche JT; Patel PA; Evans AS; Weiner M; Morozowich ST; Gordon EK; Riha H; Bracker J; Ghadimi K; Murphy S; Spitz W; MacKay E; Cios TJ; Malhotra AK; Baron E; Shaefi S; Fassl J; Weiss SJ; Silvay G; Augoustides JG
    J Cardiothorac Vasc Anesth; 2017 Feb; 31(1):1-13. PubMed ID: 28041810
    [No Abstract]   [Full Text] [Related]  

  • 2. The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2017.
    Evans AS; Weiner M; Patel PA; Baron EL; Gutsche JT; Jayaraman A; Renew JR; Martin AK; Fritz AV; Gordon EK; Riha H; Patel S; Ghadimi K; Guelaff E; Feinman JW; Dashell J; Munroe R; Lauter D; Weiss SJ; Silvay G; Augoustides JG; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):1-13. PubMed ID: 29174660
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative management of dual anti-platelet therapy.
    Webster TD; Vaishnava P; Eagle KA
    Hosp Pract (1995); 2016 Dec; 44(5):237-241. PubMed ID: 27846735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial.
    Bonaca MP; Bhatt DL; Braunwald E; Cohen M; Steg PG; Storey RF; Held P; Jensen EC; Sabatine MS
    Am Heart J; 2014 Apr; 167(4):437-444.e5. PubMed ID: 24655690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair.
    Girardi LN; Rabotnikov Y; Avgerinos DV
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):163-8. PubMed ID: 24176270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG; Qu Y; Shen H; Liu XH
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The year in Cardiothoracic and Vascular Anesthesia: selected highlights from 2011.
    Patel PA; Ramakrishna H; Andritsos M; Wyckoff T; Riha H; Augoustides JG
    J Cardiothorac Vasc Anesth; 2012 Feb; 26(1):3-10. PubMed ID: 22221506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of coronary artery bypass grafting and reduction annuloplasty for functional ischemic mitral regurgitation: a prospective multicenter study (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve).
    Grossi EA; Woo YJ; Patel N; Goldberg JD; Schwartz CF; Subramanian VA; Genco C; Goldman SM; Zenati MA; Wolfe JA; Mishra YK; Trehan N
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):91-7. PubMed ID: 21168015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events.
    Rodés-Cabau J; Dauerman HL; Cohen MG; Mehran R; Small EM; Smyth SS; Costa MA; Mega JL; O'Donoghue ML; Ohman EM; Becker RC
    J Am Coll Cardiol; 2013 Dec; 62(25):2349-2359. PubMed ID: 23583252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter Aortic Valve Replacement: Recent Evidence from Pivotal Trials.
    Carvajal T; Villablanca-Spinetto P; Augoustides JG; Morozowich ST; Shamoum FE; Gutsche JT; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):831-40. PubMed ID: 27021178
    [No Abstract]   [Full Text] [Related]  

  • 20. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.